Anti-platelet and anti-thrombogenic effects of shikimic acid in sedentary population
- 26 July 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 7 (8) , 3609-3616
Abstract
This ex vivo study was performed to evaluate the anti-platelet and anti-thrombogenic potential of shikimic acid (SA), a plant phenolic metabolite. Fasting blood samples were collected from 22 sedentary participants to analyse the effect of varying concentrations of SA (0.1 mM, 0.2 mM, 0.5 mM, 1 mM and 2 mM) on platelet surface-marker expression, platelet aggregation and biomarkers of thrombogenesis. Monocyte-platelet aggregates (CD14/CD42b) and platelet endothelial cell adhesion molecule-1 (PECAM-1 or CD31), effective indicators of thrombus formation were evaluated. Procaspase-activating compound 1 (PAC-1) and P-selectin or CD62P were used to assess platelet activation-related thrombogenesis. Adenosine diphosphate (ADP) was used to stimulate the P2Y1/P2Y12 pathway of platelet activation to mimic the in vivo thrombogenic pathway. Platelet aggregation studies utilised both ADP and collagen as exogenous platelet agonists to target both P2Y1/P2Y12 and GPVI pathways of thrombus formation. It was observed with flow cytometry that SA produced a significant antiplatelet effect on PAC-1 (p = 0.03 at 2 mM) and CD62P (p = 0.017, p = 0.036 at 1 mM and 2 mM respectively) expression in addition to lowering monocyte-platelet aggregate formation (p = 0.013, p < 0.01 and p < 0.01 at 0.5 mM, 1 mM and 2 mM respectively). SA at 1 mM concentration reduced PECAM-1 expression (p = 0.035), signifying a reduction to endothelial leucocyte migration during thrombus growth. SA did not demonstrate a platelet aggregation inhibitory effect by targeting the GPVI collagen pathway but reduced ADP induced platelet aggregation at 2 mM concentration (p < 0.01 at 2 mM). The results suggest that SA, an active metabolite of polyphenol-rich food intake, could play an important role in reducing platelet activation, aggregation related thrombus formation and biomarkers of thrombogenesis in sedentary individuals.Keywords
This publication has 45 references indexed in Scilit:
- Platelet aggregation pathwayPharmacogenetics and Genomics, 2011
- Historical perspective and future directions in platelet researchJournal of Thrombosis and Haemostasis, 2011
- Continuing Education Course #2: Current Understanding of HemostasisToxicologic Pathology, 2010
- Review: Antiplatelet Drugs: What Comes Next?Clinical and Applied Thrombosis/Hemostasis, 2010
- Fruit polyphenols and CVD risk: a review of human intervention studiesBritish Journal of Nutrition, 2010
- P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical useEuropean Heart Journal, 2009
- Platelet receptors and signaling in the dynamics of thrombus formationHaematologica, 2009
- Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosisThrombosis and Haemostasis, 2009
- P2Y12, A New Platelet ADP Receptor, Target of ClopidogrelSeminars in Vascular Medicine, 2003
- HIPPURIC ACID CLEARANCE IN BACTERIURIC PATIENTS WITH DEGREES OF RENAL IMPAIRMENT*The American Journal of the Medical Sciences, 1962